What is Bernell?
Bernell operates as a critical infrastructure provider within the vision care ecosystem, offering a comprehensive catalog of over 2,000 ophthalmic products. The company serves a sophisticated network of optometrists, ophthalmologists, and occupational therapists, positioning itself as the premier global source for vision therapy and visual rehabilitation solutions. Beyond its commercial reach, Bernell maintains a significant presence in the public sector, supplying essential eye care resources to schools and government entities. This dual-market approach, combining high-end clinical diagnostics with accessible rehabilitation tools, establishes the firm as a cornerstone of modern vision health management.
How much funding has Bernell raised?
Bernell has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Bernell
PPP
Public-Private Partnership
What's next for Bernell?
With the recent infusion of capital, Bernell is strategically positioned to scale its distribution capabilities and accelerate the development of next-generation vision therapy solutions. The company is expected to focus on expanding its digital integration for clinical diagnostics, allowing for more precise patient outcomes in rehabilitation settings. As the demand for specialized eye care continues to rise globally, Bernell's commitment to market-leading product diversity will likely serve as a catalyst for sustained growth. Future initiatives will likely prioritize the optimization of supply chain logistics to better serve its diverse institutional clientele, ensuring that essential vision care technology remains readily available to practitioners worldwide.
See full Bernell company page
